Previous 10 | Next 10 |
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has entered into agreements for the sale of 1,655,000 shares of common s...
PAVmed Inc. (PAVM) Q4 2018 Earnings Conference Call April 04, 2019, 04:30 PM ET Company Participants Mike Havrilla - Director of IR Lishan Aklog - CEO Dennis McGrath - CFO Conference Call Participants Anthony Vendetti - Maxim Group Presentation Operator Greetings,...
Conference call to be held on April 4, 2019 at 4:30 p.m. Eastern time NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today repo...
PAVmed (NASDAQ: PAVM ): FY GAAP EPS of -$0.84. More news on: PAVmed Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
March 21, 2019 Palm Beach, FL – March 21, 2019 – A recent article in a medical device industry periodical, INN, said that: “2018 has been an important year for the medical device industry as M&A, technology and regulatory catalysts have impacted the market...
NEW YORK, March 21, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the Company will report fourth quarter 2018 financial results on or be...
Motif Bio plc (NASDAQ: MTFB ) +55% on iclaprim meeting with FDA. More news on: Motif Bio plc, China Bat Group, Inc., Nevro Corp., Stocks on the move, Read more ...
PAVmed's (NASDAQ: PAVM ) NextFlo Infusion System achieved a key milestone by eliminating the need for complex and expensive electronic infusion pumps. More news on: PAVmed Inc., Healthcare stocks news, Stocks on the move, Read more ...
Groundbreaking disposable gravity-driven intravenous (IV) infusion set achieves flow accuracy comparable to expensive electronic infusion pumps, independent of IV bag height. NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or...
March 14, 2019 Palm Beach, FL – March 14, 2019 – Recent upgrades in international and domestic regulations regarding clinical trials, are both designed to protect patients, but also to upgrade the ‘new normal’ procedures in clinical trial quality and more effi...
News, Short Squeeze, Breakout and More Instantly...
PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024 PR Newswire Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK , July 30, 2024 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) ("PAVmed" or the "C...
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024 PR Newswire Conference Call and Webcast at 8:30AM Eastern Time NEW YORK , July 29, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Luc...
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire Quarterly EsoGuard ® test volume increased 31 percent sequentially NEW YORK , July 23, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("L...